Analytical Performance of the Abbott Architect i2000 Tacrolimus Assay in Chinese Patients After Renal Transplantation-Reference-Cited by-同舟云学术

Analytical Performance of the Abbott Architect i2000 Tacrolimus Assay in Chinese Patients After Renal Transplantation

Published:2010-12 Issue:10 Volume:42 Page:4534-4537
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Li Z.Y.,Yan C.L.,Yan R.,Feng Z.R.

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference19 articles.

1. Tacrolimus;Peters;Drugs,1993

2. Consensus document: therapeutic monitoring of tacrolimus (FK-506);Jusko;Ther Drug Monit,1995

3. Abbott Laboratories, Diagnostics Division: IMx System. Tacrolimus II, Ref 3C10. Abbott Park, Ill: Abbott Laboratories

4. Wallemacq P, Golfinet J, O'Morchoe S, et al: Analytical multi-site evaluation of the Abbott Architect Tacrolimus assay (Abstract). 10th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, September 9–14, 2007

5. Abbott Laboratories, Diagnostics Division: Tacrolimus, Ref 1 L77. Architect System. Abbott Park, Ill: Abbott Laboratories

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pharmacokinetics of tacrolimus in peripheral blood mononuclear cells and limited sampling strategy for estimation of exposure in renal transplant recipients;European Journal of Clinical Pharmacology;2022-05-10

2. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report;Therapeutic Drug Monitoring;2019-06

3. Falsely Elevated Tacrolimus Concentrations Using Chemiluminescence Microparticle Immunoassay in Kidney Transplant Patient;The Journal of the Korean Society for Transplantation;2016